These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 33343584)

  • 1. Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13.
    Yang J; Wu Z; Long Q; Huang J; Hong T; Liu W; Lin J
    Front Immunol; 2020; 11():610696. PubMed ID: 33343584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019.
    Doevelaar AAN; Bachmann M; Hölzer B; Seibert FS; Rohn BJ; Bauer F; Witzke O; Dittmer U; Bachmann M; Yilmaz S; Dittmer R; Schneppenheim S; Babel N; Budde U; Westhoff TH
    Crit Care Med; 2021 May; 49(5):e512-e520. PubMed ID: 33591004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.
    Joly BS; Darmon M; Dekimpe C; Dupont T; Dumas G; Yvin E; Beranger N; Vanhoorelbeke K; Azoulay E; Veyradier A
    J Thromb Haemost; 2021 Sep; 19(9):2193-2198. PubMed ID: 34219357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy.
    Henry BM; Benoit SW; de Oliveira MHS; Lippi G; Favaloro EJ; Benoit JL
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):129-136. PubMed ID: 33270980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke.
    Denorme F; Vanhoorelbeke K; De Meyer SF
    Front Immunol; 2019; 10():2884. PubMed ID: 31921147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of Laboratory Testing for ADAMTS13.
    Favaloro EJ; Pasalic L
    Methods Mol Biol; 2023; 2663():481-486. PubMed ID: 37204731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm.
    Fujimura Y; Holland LZ
    Int J Hematol; 2022 Apr; 115(4):457-469. PubMed ID: 35316498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
    Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.
    Turecek PL; Peck RC; Rangarajan S; Reilly-Stitt C; Laffan MA; Kazmi R; James I; Dushianthan A; Schrenk G; Gritsch H; Ewenstein BM; Mellgard B; Erdlenbruch W; Jain N; Binder NB; Mumford AD
    Thromb Res; 2021 May; 201():100-112. PubMed ID: 33662796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.
    Tati R; Kristoffersson AC; Manea Hedström M; Mörgelin M; Wieslander J; van Kooten C; Karpman D
    EBioMedicine; 2017 Feb; 16():302-311. PubMed ID: 28139439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.
    Akyol O; Akyol S; Chen CH
    Clin Chim Acta; 2016 Dec; 463():109-118. PubMed ID: 27746209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.
    Favaloro EJ; Henry BM; Lippi G
    Semin Thromb Hemost; 2021 Jun; 47(4):400-418. PubMed ID: 33893632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
    Xu X; Feng Y; Jia Y; Zhang X; Li L; Bai X; Jiao L
    Thromb Res; 2022 Oct; 218():83-98. PubMed ID: 36027630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory protective effect of ADAMTS-13 in murine arthritis models.
    Fukui S; Gutch S; Fukui S; Chu L; Wagner DD
    J Thromb Haemost; 2022 Oct; 20(10):2386-2393. PubMed ID: 35875933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor directly interacts with DNA from neutrophil extracellular traps.
    Grässle S; Huck V; Pappelbaum KI; Gorzelanny C; Aponte-Santamaría C; Baldauf C; Gräter F; Schneppenheim R; Obser T; Schneider SW
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1382-9. PubMed ID: 24790143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity.
    Ercig B; Arfman T; Hrdinova J; Wichapong K; Reutelingsperger CPM; Vanhoorelbeke K; Nicolaes GAF; Voorberg J
    J Biol Chem; 2021 Oct; 297(4):101132. PubMed ID: 34461090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis.
    Bettoni S; Galbusera M; Gastoldi S; Donadelli R; Tentori C; Spartà G; Bresin E; Mele C; Alberti M; Tortajada A; Yebenes H; Remuzzi G; Noris M
    J Immunol; 2017 Aug; 199(3):1021-1040. PubMed ID: 28652401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.